JJ vaccine booster dose will create more antibodies

25

A booster dose of Johnson & Johnson’s COVID-19 vaccine sharply increased levels of antibodies, according to interim data from two early-stage trials, the company said on Wednesday.

A second dose of the J&J single-dose vaccine resulted in binding antibody levels nine times higher than the levels 28 days after people received their first dose, the company said in a press release.